Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slices

Xenobiotica

Volumn 26, Issue 3, 1996, Pages 297-306

  Lake, B G ^a   Charzat, C ^b   Tredger, J M ^c   Renwick, A B ^a   Beamand, J A ^a   Price, R J ^a  

^a BIBRA INTERNATIONAL   (United Kingdom)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROCLOR 1254; BETA NAPHTHOFLAVONE; CIPROFIBRATE; CYTOCHROME P450 ISOENZYME; ENZYME INDUCING AGENT; METHYLCLOFENAPATE; PEROXISOME PROLIFERATOR; PHENOBARBITAL; PIRINIXIC ACID;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER MICROSOME; LIVER SLICE; MALE; NONHUMAN; RAT; TISSUE CULTURE;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0030009552     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609046709     Document Type: Article

References (33)

1. ACOSTA, D., SORENSEN, E. M. B., ANUFORO, D. C., MITCHELL, D. B., RAMOS, K., SANTONE, K. S., and SMITH, M. A., 1985, An in vitro approach to the study of drugs and chemicals. In Vitro Cellular and Developmental Biology, 21, 495-504.
2. ASHBY, J., BRADY, A., ELCOMBE, C. R., ELLIOTT, B. M., ISHMAEL, J., ODUM, J., TUGWOOD, J. D., KETTLE, S., and PURCHASE, I. F. H., 1994, Mechanistically based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Human and Experimental Toxicology, 13 (suppl. 2), S1-117.
3. AZRI, S., GANDOLFI, A. J., and Brendel, K., 1990, Precision-cut liver slices: an in vitro system for profiling potential hepatotoxicants. In Vitro Toxicology, 3, 309-320.
4. BARS, R. G., MITCHELL, A. M., WOLF, C. R., and ELCOMBE, C. R., 1989, Induction of cytochrome P-450 in cultured rat hepatocytes. The heterogeneous localization of specific isoenzymes using immunocytochemistry. Biochemical Journal, 262, 151-158.
5. BEAMAND, J. A., PRICE, R. J., CUNNINGHAME, M. E., and LAKE, B. G., 1993, Culture of precision-cut liver slices: effect of some peroxisome proliferators. Food and Chemical Toxicology, 31, 137-147.
6. CHENERY, R. J., 1988, The utility of hepatocytes in drug metabolism studies. In Progress in Drug Metabolism, vol. 11, edited by G. G. Gibson (London: Taylor & Francis), pp. 217-265.
7. CLARKE, S. E., BALDWIN, S. J., BLOOMER, J. C., AYRTON, A. D., SOZIO, R. S., and CHENERY, R. J., 1994, Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Chemical Research in Toxicology, 7, 836-842.
8. CONNEY, A. H., 1986, Induction of microsomal cytochrome P-450 enzymes. The first Bernard B. Brodie Lecture at Pennsylvania State University. Life Sciences, 39, 2493-2518.
9. DIRVEN, H. A. A. M., PETERS, J. G. P., GIBSON, G. G., PETERS, W. H. M., and JONGENEELEN, F. J., 1991, Lauric acid hydroxylase activity and cytochrome P-450 IV family proteins in human liver microsomes. Biochemical Pharmacology, 42, 1841-1844.
10. EDWARDS, R. J., MURRAY, B. P., MURRAY, S., SCHULTZ, T., NEUBERT, D., GANT, T. W., THORGEIRSSON, S. S., BOOBIS, A. R., and DAVIS, D. S., 1994, Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human. Carcinogenesis, 15, 829-836.
11. EDWARDS, R. J., MURRAY, B. P., SINGLETON, A. M., MURRAY, S., DAVIES, D. S., and BOOBIS, A. R., 1993, Identification of the epiptope of an anti-peptide antibody which hinds to CYP1A2 in many species including man. Biochemical Pharmacology, 46, 213-220.
12. FOXWORTHY, P. S., and EACHO, P. I., 1994, Cultured hepatocytes for studies of peroxisome proliferation: methods and applications. Journal of Pharmacological and Toxicological Methods, 31, 21-30.
13. GOKHALE, M. S., O'GORMAN, M. A., GROOPMAN, J. D., ZURLO, J., and YAGER, J. D., 1994, Maintenance and induction of cytochrome P450 mediated activities in cultured rat liver slices. Toxicologist, 14, 31.
14. GOKHALE, M. S., ZURLO, J., and YAGER, J. D., 1995. Further characterization of cultured rat liver slices for toxicological studies. Toxicologist, 15, 285.
15. GONZALEZ, F. J., 1989, The molecular biology of cytochrome P450s. Pharmacological Reviews, 40, 243-288.
16. GONZALEZ, F. J., CHESPI, C. L., and GELBOIN, H. V., 1991, cDNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment. Mutation Research, 247, 113-127.
17. JAPENGA, A. C., DAVIES, S., PRICE, R. J., and LAKE, B. G., 1993, Effect of treatment with pyrazine and some derivatives on cytochrome P450 and some enzyme activities in rat liver. Xenobiotica, 23, 169-179.
18. 2-terminal amino acid sequences of human and rat kidney fatty acid ω-hydroxylases. Biochimica et Biophysica Acta, 1123, 156-162.
19. LAKE, B. G., 1995, Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annual Review of Pharmacology and Toxicology, 35, 483-507.
20. LAKE, B. G., BEAMAND, J. A., JAPENGA, A. C., RENWICK, A., DAVIES, S., and PRICE, R. J., 1993, Induction of cytochrome P-450-dependent enzyme activities in cultured rat liver slices. Food and Chemical Toxicology, 31, 377-386.
21. LAKE, B. G., and LEWIS, D. K. V., 1996, The CYP4 family. In Cytochromes P450: Metabolic and Toxicological Aspects, edited by C. Ioannides (CRC Press, Boca Raton) (in press).
22. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L., and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
23. NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., OKUDA, K., and NEBERT, D. W., 1993, The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology, 12, 1-51.
24. OKEY, A. B., 1990, Enzyme induction in the cytochrome P-450 system. Pharmacology and Therapeutics, 45, 241-298.
25. PAINE, A. J., 1990, The maintenance of cytochrome P-450 in rat hepatocyte culture: some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P-450 system. Chemico-Biological Interactions, 74, 1-31.
26. PALMER, C. N. A., RICHARDSON, T. H., GRIFFIN, K. J., HSU, M.-H., MUERHOFF, A. S., CLARK, J. E., and JOHNSON, E. F., 1993, Characterization of a cDNA encoding a human kidney, cytochrome P-450 4A fatty acid ω-hydroxylase and the cognate enzyme expressed in Escherichia coli. Biochimica et Biophysica Acta, 1172, 161-166.
27. ROGIERS, V., and VERCRUYSSE, A., 1993, Rat hepatocyte cultures and co-cultures in biotransformation studies of xenobiotics. Toxicology, 82, 193-208.
28. SAAD, B., SCHOLL, F. A., THOMAS, H., SCHAWALDER, H., STREIT, V., WAECHTER, F., and MAIER, P., 1993, Crude liver membrane fractions and extracellular matrix components as substrata regulate differentially the preservation and inducibility of cytochrome P-450 isoenzymes in cultured rat hepatocytes. European Journal of Biochemistry, 213, 805-814.
29. SIDHU, J. S., FARIN, F. M., and OMIECINSKI, C. J., 1993, Influence of extracellular matrix overlay on phenobarbital-mediated induction of CYP2B1, 2B2 and 3A1 genes in primary adult rat hepatocyte culture. Archives of Biochemistry and Biophysics, 301, 103-113.
30. SMITH, P. F., MCKEE, R., GANDOLFI, A. J., KRUMDIECK, C. L., FISHER, R., and BRENDEL, K., 1989, Precision cut liver slices: a new in vitro tool in toxicology. In In Vitro Toxicology: Model Systems and Methods, edited by C. A. McQueen (New Jersey: Telford Press), pp. 93-130.
31. STEWART, A. R., DANNAN, G. A., GUZELIAN, P. S., and GUENGERICH, F. P., 1985, Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes. Molecular Pharmacology, 27, 125-132.
32. WORTELBOER, H. M., DE KRUIF, C. A., VAN IERSEL, A. A. J., FALKE, H. E., NOORDHOEK, J., and BLAAUBOER, B. J., 1991, Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities. Biochemical Pharmacology, 42, 381-390.
33. WRIGHT, M. C., and PAINE, A. J., 1992, Evidence that the loss of rat liver cytochrome P450 in vitro is not solely associated with the use of collagenase, the loss of cell-cell contacts and/or the absence of an extracellular matrix. Biochemical Pharmacology, 43, 237-243.